medigraphic.com
ISSN 1405-0315 (Print)

2012, Number 2

<< Back Next >>

Rev Mex Enf Cardiol 2012; 20 (2)

Integration of unconventional coronary risk factors during nursing diagnoses

Landeros-Olvera E, Nava-González EJ, Pérez-Noriega É, Pinson LA, Bastarrachea RA

Language: Spanish
References: 32
Page: 71-77
PDF size: 156.81 Kb.


ABSTRACT

Evidence suggests non conventional cardiovascular risk factors could be considered in nursing diagnostics construction aiming to prevent a sudden infarction within a group of individuals that show traditional factors at normal limits. Objectives: a) point out the importance of assembling some clinical observational and laboratory elements in the nursing evaluation in order to integrate traditional and non conventional risk factors for a coronary arterial disease; b) explain and understand the molecular bases causing such non conventional risk factors in the process of the arteriosclerosis plaque formation. The proposed diagnostics wording for the submitted cases was done based on the PES format assisted by the Orem’s Self-Care Deficit Model and the Alfaro’s proposal suggesting a NANDA nomenclature. Discussion: Cardiovascular risk diagnostics wording requires more than a clinical- observational evaluation; nursing needs to know the advances on the coronary risk factors scrutiny from the intimacy of molecular biology and make use of laboratory resources to lay foundation for diagnostics and its interventions.


REFERENCES

  1. Organización Mundial de la Salud. Sistema de información estadística de la OMS (WHOSIS) [Monografía en internet]. México: OMS. 2012 [acceso 15 de enero de 2010]. Disponible en: http://www.who.int/whosis/es/index.html

  2. Organización Panamericana de la Salud. Salud en las Américas. [Monografía en línea]. 622. Washington, D.C. EUA: Publicación Científica y Técnica. 2007 [acceso 18 de marzo de 2009]. Disponible en: http://www.paho.org/hia/documentos/Esp/HIAbookletCompiled%20-%20Esp.pdf

  3. American Heart Association. Risk factors and coronary heart disease. [Monografía en Internet]: AHA scientific position AHA. 2009 [acceso 16 de enero de 2010]. Disponible en: http://74.125.95.132/search?q=cache:LvWeQx2rv9QJ:www.americanheart.org/presenter.jhtml%3Fidentifier%3D4726+obesity+risk+factor+American+Heart+Association.&cd=2&hl=es&ct=clnk&gl=mx

  4. Summary of the Second Report of the National Cholesterol Education Program. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 1993; 269: 15-30.

  5. Kannel WB, Evans JC, Piper S, Murabito JM. Angina pectoris is a stronger indicator of diffuse vascular atherosclerosis than intermittent claudication: Framingham study. J Clin Epidemiol. 2008; 61(9): 951-957.

  6. American College of Sport Medicine. Guidelines for exercise testing and prescription. 8th ed. Philadelphia, EUA: Lippincott Williams & Wilkins, 2010.

  7. Bastarrachea RA. Prevención cardiovascular: los olvidados factores de riesgo no convencionales en la era de la adiponectina. Obesidad y Diabetes. 2007; 13: 5-8.

  8. Alfaro-LeFevre R. Applying nursing process. A tool for critical nursing. 7th ed. Philadelphia: Lipincot Williams & Wilkins, 2010.

  9. Salas SS, Alzaga BMT, Landeros OE, Chávez DR. Testimonios de la mujer con angina. El dolor de pecho en la mujer mexicana. Index Enferm (Gran). 2003; 42: 9-13.

  10. Doenges ME, Moorhouse MF, Murr AC. Nursing diagnosis manual. 2nd ed. Philadelphia: F.A. DavisCompany, 2008.

  11. Orem DE. Nursing: Concepts of practice. 5th ed. St. Louis: Mosby, 1995.

  12. Barnsteiner J, Provost S. How to implement evidence-based-practice: Some tried and true pointers. Rev Reflections on Nursing Leadership. 2002; 28(2): 18.

  13. Olvera E, Amezcua M. Enfermería basada en evidencia: principios básicos. Rev Mexicana de Enfermería Cardiológica. 2005; 13(1-2): 65-66.

  14. Bastarrachea RA, Laviada H, Machado I, Jack Jr, López JC, Comuzzie AG. El receptor de insulina como objetivo farmacogenómico: potenciando su señalización intracelular. Rev Endocrinología y Nutrición. 2005; 13(4): 180-189.

  15. Hanna-Maaria L, Timo AL, Jaakko TJ, Jukka TS. Hyperinsulinemia and the Risk of Cardiovascular Death and Acute Coronary and cerebrovascular events in men: The Kuopio ischemic heart disease risk factor study. Arch Intern Med. 2000; 160: 1160-1168.

  16. Batarrachea RA, López-Alvarenga JC, Bolado-García VE, Téllez-Mendoza J, Laviada-Molina, Comuzzie AG. Macrófagos, inflamación, tejido adiposo, obesidad y resistencia a la insulina. Gaceta Médica Mexicana. 2007; 143(6): 505-512.

  17. Masahiro K, Shinji K, Satoru S, Toshiharu K, Satoru M, Noriyuki O et al. Osaka CAD study group association of hypoadiponectinemia with coronary artery disease in men. Rev Arterioscler Thromb Vasc Biol. 2003; 23: 85-89.

  18. Bastarrachea R, Fuenmayor R, Brajkovich I, Comuzzie A. Entendiendo las causas de la obesidad a través de la biología celular del adipocito. Rev Venezolana de Endocrinología Metabólica. 2005; 3 (3): 20-29.

  19. Wicek A, Adamczak M, Chudek J. Adiponectin- an adipokine with unique metabolic properties. Rev Nephrology Dialysis Transplantation. 2007; 22: 981-988.

  20. Takashi K, Toshimasa Y. Adiponectin and adiponectin receptors. Rev Endocrine Reviews. 2005; 26(3): 439-451.

  21. Hivert MF, Sullivan LM, Fox CS, Nathan DM, D’Agostino RB, Wilson PW et al. Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. Rev J Clin Endocrinol Metab. 2008; 93(8):3165-3172.

  22. Guadalajara BF. Cardiología. 6ta ed. México: Méndez Editores, 2006.

  23. Contois JH, McConell JP, Sethi AA, Csako G, Devaraj S, Hoefner DM et al. Apolipoprotein B and cardiovascular disease risk: position statement from de AACC lipoprotein and vascular disease division working group on best practices. Clin Chem. 2009; 55(3): 407-419.

  24. Ferrieri P. Jones Criteria Working Group. Proceedings of the Jones Criteria workshop. Circulation. 2002; 106(19): 2521-2523.

  25. Rückerl R, Peters A, Khuseyinova N, Andreani M, Koenig W, Meisinger C et al. Determinants of the acute-phase protein C-reactive protein in myocardial infarction survivors: the role of comorbidities and environmental factors. Clin Chem. 2009; 55(2): 322-335.

  26. Ridker PM. C-Reactive Protein: Eighty Years from Discovery to Emergence as a Major Risk Marker for Cardiovascular Disease. Amer Assoc Clin Chem. 2009; 55: 209-215.

  27. Klainpell MR. Outcome assessment in advanced nursing practice. Springer Publishing Company, 2001.

  28. Landeros OE, Gallegos CE. Capacidades de autocuidado y percepción del estado de salud en personas con obesidad y sin obesidad. Rev Mex Enferm Cardiol. 2005; 13 (1-2): 20-24.

  29. Shaw K, O’Rourke P, Del Mar C, Kenardy J. Psychological interventions for overweight or obesity (Review). The Cochrane Collaboration. Published by: JohnWiley & Sons. 2009; Ltd. 1: 1-76.

  30. López-Alvarenga J, González GL. Enfermedades asociadas a la obesidad. Revista de Endocrinología y Nutrición. 2001; 9(2): 77-85.

  31. Wildman RP, Muntner P, Reynolds K, McGinn A, Rajpathak S, Wylie-Rosett J et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering. Arch Intern Med. 2008; 168(15): 1627-1624.

  32. Bastarrachea RA., Laviada-Molina H., Vázquez-Chávez C. Análisis crítico de los nuevos criterios que sustentan el diagnóstico de prediabetes. Revista de Endocrinología y Nutrición. 2004; 12(2): 90-96.




2020     |     www.medigraphic.com